Watch Resverlogix, its not trading big volume now, those who get in before the herd shows up are the ones who will see massive gains imo. The only company with a Selective BET Inhibitor in late stage development.
$RVX.TO on Canada's big board, or $RVXCF in the USA
Apabetalone is in a Phase III trial that's been running for 2 years....Scientific proof takes a lot of time and a lot of money, almost like developing a Gold Mine....but once a drug is approved the pay off can be massive..